3649 results for «2333»
3649 results
DCB - Going beyond in-stent restenosis
20 May 2026 – From EuroPCR 2026
This session examines the expanding role of drug-coated balloons (DCB) beyond in-stent restenosis, including treatment of acute coronary syndromes, calcified lesions, and bifurcations. It reviews current evidence supporting DCB-based revascularization and outlines essential procedural steps to optimize outcomes.
Reliability and application of angio-based physiology in daily work
20 May 2026 – From EuroPCR 2026
This session evaluates the reliability and clinical application of angiography-based physiological assessments in daily practice. Topics include comparisons of angiography-derived microvascular resistance and flow metrics with invasive methods, reproducibility of quantitative flow ratio (QFR), and its correlation with symptom burden and other imaging modalities.
When the angiogram shows no answer for your AMI patient: what's next?
20 May 2026 – From EuroPCR 2026
This session focuses on non-occlusive causes of acute coronary syndromes (ACS) when angiograms do not reveal clear pathology. It emphasizes the diagnostic value of intracoronary imaging for conditions such as MINOCA and spontaneous coronary artery dissection (SCAD), and discusses optimal treatment strategies and prognostic considerations.
New tools for risk stratification in STEMI
20 May 2026 – From EuroPCR 2026
This session highlights novel tools and scores for risk stratification in ST-elevation myocardial infarction (STEMI) patients. It covers prognostic indices such as the index of microcirculatory resistance, the PREDICT-STEMI score, thrombus characteristics, sex differences in outcomes, renal impairment impacts, and benefits of complete revascularization strategies.
Bleeding and thrombotic risk in LAA closure patients
20 May 2026 – From EuroPCR 2026
This session provides a thorough examination of bleeding and thrombotic risks in patients undergoing left atrial appendage (LAA) closure. It reviews risk factors for device-related thrombosis, compares anticoagulation strategies post-procedure, and presents real-world clinical outcomes, particularly in high bleeding risk populations and special groups such as...
When transcatheter LAA closure becomes challenging
20 May 2026 – From EuroPCR 2026
This session addresses the technical and clinical challenges encountered during transcatheter left atrial appendage (LAA) closure, including management of peri-device leaks, alternative access routes like transhepatic approaches, complications following surgical closures, and rare procedural adversities such as accidental aortic puncture.
Prevention and management of PCI complications
20 May 2026 – From EuroPCR 2026
This session addresses the prevention and management strategies for complications arising during percutaneous coronary intervention (PCI). It presents real-world cases including management of entrapped guidewires, thrombosed aneurysms, catheter kinking, stent retrieval challenges, and complex retrieval scenarios, offering valuable insights into effective complication resolution techniques.
Post myocardial infarction and iatrogenic VSDs: case-based decision taking
21 May 2026 – From EuroPCR 2026
This session focuses on decision-making in post-myocardial infarction and iatrogenic ventricular septal defects (VSDs) through illustrative cases. It covers transcatheter closure techniques, zero contrast interventions guided by echocardiography, and innovative approaches to late and residual VSDs following congenital heart surgery.
Challenging clinical scenarios in STEMI
21 May 2026 – From EuroPCR 2026
This session explores challenging clinical scenarios in STEMI, including coronary embolisation from aortic valve vegetation, blunt chest trauma-related STEMI, intramural hematoma diagnostics with multimodality imaging, acute stent thrombosis during dengue recovery, and advanced clot removal techniques beyond standard aspiration devices.
Haemodynamic support: from shock to complex high-risk interventional problems
21 May 2026 – From EuroPCR 2026
This session examines haemodynamic support from cardiogenic shock through to complex high-risk interventional cardiology procedures. It features registry data, clinical outcomes, and procedural techniques including mechanical circulatory support and arterial access strategies.
Navigating the complexity of high bleeding risk
20 May 2026 – From EuroPCR 2026
Focusing on patients with high bleeding risk undergoing PCI, this session presents contemporary evidence on prevalence, procedural strategies with different stent types, antiplatelet therapy considerations including diabetic and sex-specific outcomes, and novel technologies such as sirolimus-coated balloons and machine learning models for restenosis prediction.
From entry to exit: managing arterial access for nurses and allied professionals
20 May 2026 – From EuroPCR 2026
This session focuses on arterial access management tailored for nurses and allied health professionals. It highlights key anatomical landmarks, demonstrates the purpose and use of common vascular closure devices through live manikin demonstrations, and discusses the essential role of nursing and allied staff in vascular access...
Risk stratification and reperfusion strategies for acute and subacute pulmonary embolism
21 May 2026 – From EuroPCR 2026
Focus on risk stratification and reperfusion strategies for acute and subacute pulmonary embolism through this session. It discusses the impact of elective endovascular therapies in intermediate-high risk patients, intraprocedural complications, and early mortality associated with catheter interventions. Additionally, it reviews real-world outcomes of catheter-directed therapy, national...
Optimal use of dedicated device for calcified lesions
20 May 2026 – From EuroPCR 2026
This session delves into the optimal utilization of dedicated devices for managing complex coronary calcification. Explore decision-making strategies involving orbital atherectomy and cutting balloon techniques, as well as advanced approaches like contact intravascular lithotripsy for stented calcified nodules. Additional focus is given to ablative and modifying...
Sealing the deal: catheter based solutions for aortic disease
21 May 2026 – From EuroPCR 2026
Examine catheter-based solutions for aortic disease management, featuring innovative approaches to preserving branch vessels, managing vascular complications, and repairing challenging aneurysms with endografts and occluders.
STEMI management around the world
21 May 2026 – From EuroPCR 2026
This session presents a global perspective on STEMI management, addressing strategies to reduce reperfusion delays through nurse-integrated pathways and comparing intracoronary versus intravenous Tirofiban use during primary PCI. It includes epidemiological insights from Rwanda and Egypt, evaluates thrombo-aspiration practices in Sub-Saharan Africa, and examines outcomes in...
Complications in coronary interventions
20 May 2026 – From EuroPCR 2026
This session reviews uncommon and challenging complications encountered during coronary interventions. Cases include brachial arteriovenous fistula following radial access, retained guidewires, coronary sinus perforation during device implantation, and complex atherectomy procedures, emphasizing preparedness and management strategies.
Various NSTEMI cases
21 May 2026 – From EuroPCR 2026
This session presents diverse NSTEMI case studies addressing complex diagnostic and interventional challenges, including coronary dissections, intramural hematomas, ischemic complications, and functional lesion assessment.
How to achieve coronary patency during TAVI
21 May 2026 – From EuroPCR 2026
This session addresses techniques to achieve coronary artery patency during transcatheter aortic valve implantation (TAVI), highlighting advanced procedural approaches and management of high-risk anatomical scenarios.
Challenges during PCI on bifurcation
20 May 2026 – From EuroPCR 2026
This session addresses the complexities of percutaneous coronary intervention (PCI) in bifurcation lesions. It discusses decision-making strategies, techniques to avoid implanting permanent devices, the use of IVUS-guided laser atherectomy for restenosis, and approaches to challenging double bifurcation lesions including drug-coated balloon therapy.